This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Spigler provides insight into the development of new patient-focused guidelines for managing hyperkalemia in CKD and the importance of providing patients with such resources.
Panelists discuss how health care providers can effectively utilize white papers and other tools in practice, as well as additional resources available for further learning about chronic kidneydisease (CKD) and type 2 diabetes management.
Cardiometabolic health education leader CMHC announced that its digital education has been streamlined into 12 hubs organized by therapeutic or clinical topics for focused learning The digital education from worldwide cardiometabolic event leader CMHC has undergone a reorganization.
His unwavering dedication and contributions to CMHC as a renowned expert, educator, and mentor in the cardiorenal metabolic space have left an indelible mark on our community. As these diseases and risk factors exist in a continuum, they cannot be treated in silos, which is, unfortunately, what tends to happen in clinical practice.
Here’s how to reset it: For CMHC website access: Reach out to Andi Wilson, Director of Educational Sales, at andi.wilson@informa.com , or Carla Villagran, Sales Support and Partnerships, at carla.villagran@informa.com for help with resetting your password. Congratulations on earning your CME credits—well done! What If I Forgot My Password?
Introduction:Smoking is a well-known risk factor for atherosclerotic cardiovascular disease and kidney failure among patients with chronic kidneydisease (CKD). Circulation, Volume 150, Issue Suppl_1 , Page A4142036-A4142036, November 12, 2024. However, the association of former and current smoking status (vs.
Bakris’ distinguished career as a leading educator and mentor. Themed “Decoding the Constellation of Cardiometabolic Health and Risk Factors,” this year’s congress will tackle the growing health threat posed by cardiometabolic diseases, affecting 47 million people in the US. Boca Raton, FL, Aug. Chair: Erin D.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.
2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidneydisease, diabetes and obesity. based, multidisciplinary conference addressing cardiometabolic disease prevention, management, and treatment.
More recently, the nonsteroidal MRA finerenone improved the HF outcomes of patients with HF with preserved ejection fraction, expanding the benefits previously seen among patients with diabetes and albuminuric chronic kidneydisease. The use of MRAs has been limited due to excessive concern about hyperkalemia.
Background:The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) trial showed cardiovascular disease (CVD) benefits of semaglutide therapy in patients with type 2 diabetes mellitus (T2DM).Purpose:To year follow-up time).Results:Among Results:Among 5002 (projected to 34.0
Eko : AI-powered heart sound and EKG sensors paired with FDA-approved software for heart disease monitoring. RenalytixAI : Provides AI-enabled diagnostic solutions for early detection and management of kidneydisease. Viz.ai : Uses AI to enhance care coordination and improve outcomes in cardiovascular care.
Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidneydisease, hypertension, and nephropathy progression. His work was particularly influential in understanding racial disparities in disease progression and developing targeted interventions.
Implementation strategy: Utilize decision aids and patient education materials to facilitate informed discussions about treatment options, risks, and benefits. Open Communication Encouraging open, honest, and regular communication between patients and healthcare providers is essential. Key contributions: Advanced cardiac imaging (e.g.,
milla1cf Fri, 06/28/2024 - 19:07 June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa , its flagship health equity initiative, to target a broader range of non-communicable diseases (NCDs), including chronic kidneydisease (CKD) as well as hypertension and cardiovascular disease.
Notes: Approved after initial rejection two years prior based on safety data from Japan, where the drug had been used since 2020 It can only be used in kidneydisease patients on dialysis for at least 3 months. CMHC remains committed to providing the latest insights and medical education on these groundbreaking therapies.
Measuring eGFR and albuminuria is recommended for assessing kidneydisease in all hypertensive patients. Set for October 17-19, 2024, in Boston, MA, this premier medical education conference offers a unique opportunity to engage in one-on-one discussions with leading cardiometabolic experts.
Factors associated positively with ISTAF were higher age, lower education level, and alcohol use disorder, whereas vascular disease, heart failure, chronic kidneydisease cancer, and psychiatric disorders were less probable with ISTAF. The annual proportion of ISTAF among patients with AF decreased from 6.0%
Because CMHC is committed to forging relationships with organizations that share a pursuit of bettering patient outcomes through unparalleled provider education, many like-minded regional and national organizations will be in attendance.
Among those ages 65 and older, nearly 50% who underwent limb amputation died within one year after surgery, according to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association. Foot care is important for patients across the four clinical presentation subsets of PAD.
Panelists discuss how multidisciplinary teams can enhance holistic patient care in managing chronic kidneydisease (CKD) and its associated risks, emphasizing the importance of ongoing education and collaboration across disciplines, along with established protocols for screening and testing in health systems and the challenges faced in their implementation (..)
Asthma significantly increased the prevalence of stroke among participants aged 1844 years old, with a BMI 18.5029.99kg/m2, with low education levels, and with a PIR<1.00. Asthma also increased the prevalence of angina in females, non-Hispanic Blacks, participants aged 4559 years old, with a BMI30.00kg/m2, and with a PIR<1.00.
Research stresses the use of these pillars of therapy, highlighting that combinations of these agents can significantly reduce the progression of chronic kidneydisease (CKD) and lower cardiovascular risks. Regular treatment plan reviews and patient education can increase the uptake of these practices.
Over three days, more than 25 acclaimed experts delivered 22 forward-thinking, clinically relevant educational sessions. Additionally, 10% of the global population suffers from chronic kidneydisease , with diabetes and hypertension as significant risk factors. cardiometabolic health CME/CE conference: the 19th Annual CMHC.
In contrast, nontraditional risk factors, such as blood clots in the veins, migraine with aura, chronic kidneydisease, chronic liver disease or cancer, were more strongly associated with stroke among study participants with a PFO. Among participants with a PFO, each traditional risk factor increased the risk of stroke by 18%.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content